Publicacions en col·laboració amb investigadors/es de Hospital Universitario de Basurto (24)

2024

  1. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Fibroblast Activation Protein-α (FAP) Identifies Stromal Invasion in Colorectal Neoplasia

    The American journal of surgical pathology, Vol. 47, Núm. 9, pp. 1027-1033

  2. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2021

  1. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  2. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases

    Aging, Vol. 12, Núm. 11, pp. 10337-10358

  2. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. (Pro)renin receptor expression increases throughout the colorectal adenoma—Adenocarcinoma sequence and it is associated with worse colorectal cancer prognosis

    Cancers, Vol. 11, Núm. 6

  2. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence

    International Journal of Medical Sciences, Vol. 16, Núm. 6, pp. 813-821

2017

  1. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8

2015

  1. Altered activity and expression of cytosolic peptidases in colorectal cancer

    International Journal of Medical Sciences, Vol. 12, Núm. 6, pp. 458-467

  2. Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients

    Journal of Investigative Medicine, Vol. 63, Núm. 5, pp. 740-746

  3. Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. Prolyl endopeptidase activity is correlated with colorectal cancer prognosis

    International Journal of Medical Sciences, Vol. 11, Núm. 2, pp. 199-208

2013

  1. Altered peptidase activities in thyroid neoplasia and hyperplasia

    Disease Markers, Vol. 35, Núm. 6, pp. 825-832

  2. Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer

    Translational Research, Vol. 162, Núm. 5, pp. 297-308

2012

  1. Erratum to "Activity of soluble aminopeptidase A and dipeptidyl peptidase IV and membrane-bound aminopeptidase B and pyroglutamyl peptidase I in adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis" [Int. J. Pediatr. Otorhinolaryngol. 75 (November (11)) (2011) 1399-1403]

    International Journal of Pediatric Otorhinolaryngology

  2. The impact of peptidase activity on clear cell renal cell carcinoma survival

    American Journal of Physiology - Renal Physiology, Vol. 303, Núm. 12

2011

  1. Activity of soluble aminopeptidase A and dipeptidyl peptidase IV and membrane-bound aminopeptidase B and pyroglutamyl peptidase I in adenoid hyperplasia, tonsillar hyperplasia and chronic tonsillitis

    International Journal of Pediatric Otorhinolaryngology, Vol. 75, Núm. 11, pp. 1399-1403

  2. Altered dipeptidyl peptidase IV and prolyl endopeptidase activities in chronic tonsillitis, tonsillar hyperplasia and adenoid hyperplasia

    International Journal of Pediatric Otorhinolaryngology, Vol. 75, Núm. 3, pp. 347-350